NASDAQ · GNLX

Genelux Corp

Closing price · Nov 13, 2026 $1.865

Latest quarter · ended Jun 30, 2026

Cash got weaker

descriptionFiled Aug 13, 2026

Cash from operationsBetter

−$6.44M

Sep '24Jun '26

vs. −$7.06M a year ago

Share countDiluting

+19.8%

Sep '24Jun '26

45.25M shares vs. 37.77M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026

account_balance
2 funds bought, 0 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
info
21 real insider sales in 12 months. $232K in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

74 funds report owning GNLX, up from 70

Holdings as of Jun 30, 2026

New14

Added17

Held32

Trimmed11

Sold out10

Last quarter

Who bought and who sold

Apr–Jun 2026

Woodward Diversified Capital, LLC

+7%

CM Management, LLC

+60%

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale

Last 6 months. A wider screen shows 12.

Showing 21 real trades. Hidden: 9 stock grants, 3 planned 10b5-1 sales. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Nov 3 Thomas Zindrick President and CEO Open-market sale $6.32K 3,089 sh at $2.05 Sold 1% of stake

Nov 3 Joseph Cappello Chief Technical Officer Open-market sale $1.36K 668 sh at $2.04 Sold 1% of stake

Nov 3 Yong Yu Chief Scientific Officer Open-market sale $1.34K 668 sh at $2.01 Sold 1% of stake

Aug 31 Thomas Zindrick President and CEO Open-market sale $92K 34,463 sh at $2.67 Sold 3% of stake

Aug 31 Joseph Cappello Chief Technical Officer Open-market sale $28.1K 10,257 sh at $2.74 Sold 3% of stake

Aug 31 Yong Yu Chief Scientific Officer Open-market sale $26.6K 9,683 sh at $2.75 Sold 4% of stake

Aug 4 Thomas Zindrick President and CEO Open-market sale $8.92K 3,023 sh at $2.95 Sold 1% of stake

Aug 4 Joseph Cappello Chief Technical Officer Open-market sale $1.93K 653 sh at $2.95 Sold 1% of stake

Aug 4 Yong Yu Chief Scientific Officer Open-market sale $1.92K 653 sh at $2.94 Sold 1% of stake

Jul 1 John Smither Director Open-market sale $34.9K 12,000 sh at $2.91 Sold 12% of stake

Show 11 older real trades

Jun 3 Ralph Smalling Head of Regulatory Open-market sale $563 192 sh at $2.93 Sold 1% of stake

May 11 Thomas Zindrick President and CEO Open-market sale $8.23K 2,798 sh at $2.94 Sold 1% of stake

May 11 Joseph Cappello Chief Technical Officer Open-market sale $1.8K 605 sh at $2.97 Sold 1% of stake

May 11 Yong Yu Chief Scientific Officer Open-market sale $1.8K 605 sh at $2.97 Sold 1% of stake

May 11 Ralph Smalling Head of Regulatory Open-market sale $805 270 sh at $2.98 Sold 1% of stake

Mar 25 Ralph Smalling Head of Regulatory Open-market sale $602 240 sh at $2.51 Sold 1% of stake

Mar 24 Thomas Zindrick President and CEO Open-market sale $8.67K 3,582 sh at $2.42 Sold 1% of stake

Mar 24 Joseph Cappello Chief Technical Officer Open-market sale $2.19K 906 sh at $2.42 Sold 1% of stake

Mar 24 Yong Yu SVP, Clinical Development Open-market sale $2.19K 906 sh at $2.42 Sold 1% of stake

Mar 24 Ralph Smalling Head of Regulatory Open-market sale $835 345 sh at $2.42 Sold 1% of stake

Dec 5 Ralph Smalling Head of Regulatory Open-market sale $774 165 sh at $4.69 Sold 1% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in GNLX

As of Jun 30, 2026

Fund	Owns	Value	Change
Woodward Diversified Capital, LLC	5.0%	$6.81M	+7%
Vanguard Capital Management LLC	3.7%	$5.05M	−1%
Bleichroeder LP	3.1%	$4.16M	Same
BlackRock, Inc.	1.0%	$1.32M	+8%
Geode Capital Management, LLC	1.0%	$1.32M	−3%

"Owns" is shares reported divided by shares outstanding.